Cargando…
Is there a difference between GBS triggered by COVID-19 and those of other origins?
BACKGROUND: Since the outbreak of the coronavirus disease 2019 (COVID-19), an increasing number of Guillain–Barré syndrome (GBS) cases following the infection has been reported. The aim of our study was to detect patients with GBS treated in our hospital over a 1-year period and to compare the chara...
Autores principales: | Radišić, Vanja, Ždraljević, Mirjana, Perić, Stojan, Mladenović, Branka, Ralić, Branislav, Jovanović, Dejana R., Berisavac, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107584/ https://www.ncbi.nlm.nih.gov/pubmed/35601875 http://dx.doi.org/10.1186/s41983-022-00486-6 |
Ejemplares similares
-
Traumatic lingual hematoma after generalized tonic–clonic seizure in a patient with an acquired coagulopathy
por: Ralić, Branislav, et al.
Publicado: (2022) -
Downregulation of LKB1/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain–Barre Syndrome
por: Paunovic, Verica, et al.
Publicado: (2022) -
GBS-SBG - GBS Serotyping by Genome Sequencing
por: Tiruvayipati, Suma, et al.
Publicado: (2021) -
NanoGBS: A Miniaturized Procedure for GBS Library Preparation
por: Torkamaneh, Davoud, et al.
Publicado: (2020) -
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
por: Peric, Stojan, et al.
Publicado: (2022)